Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Ho

Vaccine

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vaccine|May 26, 2009
A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin ADavid F Gardiner, Talia Rosenberg, Jerry Zaharatos, et al.
Vaccine|November 9, 2011
HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in miceGerasimos J Zaharatos, Jian Yu, Craig Pace, et al.
Vaccine|September 3, 2005
Multiple-site DNA vaccination enhances immune responses in miceDavid F Gardiner, Yaoxing Huang, Sankha Basu, et al.
Vaccine|July 6, 2010
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine developmentDavid Franco, Wenjing Li, Fang Qing, et al.
Vaccine|March 11, 2008
Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramideYaoxing Huang, Alex Chen, Xiangming Li, et al.
Vaccine|July 5, 2005
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirusPatrick C Y Woo, Susanna K P Lau, Hoi-Wah Tsoi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vaccine|May 26, 2009
A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin ADavid F Gardiner, Talia Rosenberg, Jerry Zaharatos, et al.
Vaccine|November 9, 2011
HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in miceGerasimos J Zaharatos, Jian Yu, Craig Pace, et al.
Vaccine|September 3, 2005
Multiple-site DNA vaccination enhances immune responses in miceDavid F Gardiner, Yaoxing Huang, Sankha Basu, et al.
Vaccine|July 6, 2010
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine developmentDavid Franco, Wenjing Li, Fang Qing, et al.
Vaccine|March 11, 2008
Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramideYaoxing Huang, Alex Chen, Xiangming Li, et al.
Vaccine|July 5, 2005
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirusPatrick C Y Woo, Susanna K P Lau, Hoi-Wah Tsoi, et al.
Pageof 1